Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1HIV Infections 1

Interventions

Cisplatin 31Brachytherapy 13Radiotherapy 12Paclitaxel 10Taxes 6Gemcitabine 6Platinum 51,2-diaminocyclohexaneplatinum II citrate 5Topotecan 4Radiotherapy, Intensity-Modulated 4Radiation 4Carboplatin 4Surgical Procedures, Operative 3Fluorouracil 3Cetuximab 3Vinorelbine 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Pemetrexed 2Chemotherapy, Adjuvant 2Celecoxib 2Capecitabine 2Amifostine 2sulfan blue 1oncogene protein E7, Human papillomavirus type 16 1iso-sulfan blue 1ethanethiol 1carfilzomib 1brivanib 1Vindesine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Uterine Cervical Neoplasms × Remote Patient Monitoring × Clear all
NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

AIDS Malignancy Consortium

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡